Loading market data...

Concord Biotech IPO

Fermentation Pharma / API - Listed on 18 August 2023

+21.5% listing gain
Issue Price (Upper)
Rs 741
Listing Price
Rs 900.05
Closing Price (NSE)
Rs 942.8
Total Subscription
24.86x

Concord Biotech IPO listing summary

Concord Biotech (Fermentation Pharma / API) closed its IPO window in 2023 and listed on NSE and BSE on 18 August 2023 at an upper band issue price of Rs 741, opening at Rs 900.05 for a listing gain of +21.5% and closing day one at Rs 942.8 (+27.2% on closing basis). The IPO was subscribed 24.86x overall - QIB 67.67x, HNI/NII 16.99x, Retail 3.78x. The total issue size was Rs 1,550.52 Cr (Fresh Issue Rs 0 Cr, OFS Rs 1550.52 Cr). IPO GMP data, subscription trends across Day 1 - Day 3 and Nifty performance around the listing window are detailed below.

Listing day performance

Listing Gain (Open)
+21.46%
Listing Gain (Close)
+27.23%
Day Change After Listing
+5.77%
Retail Quota
35.0%

Subscription breakdown

Final (Day 3) subscription

Number of times each investor category subscribed by close of Day 3.

QIB67.67x
HNI / NII16.99x
Retail3.78x
Overall24.86x

Day-wise overall subscription

How overall subscription built up across the three-day issue window.

Day 10.58x
Day 22.72x
Day 3 (Final)24.86x

Concord Biotech IPO GMP history

Grey market premium (GMP) tracked day-by-day across the IPO window. Absolute GMP is the premium in rupees over the upper issue price; GMP % is that premium as a percent of the issue price.

DayGMP (Rs)GMP %
Day 1Rs 220+29.69%
Day 2Rs 170+22.94%
Day 3Rs 170+22.94%
Day 4Rs 180+24.29%
Day 5Rs 160+21.59%

GMP Prediction vs IPOGyani AI Prediction

Comparison between market-based GMP prediction and IPOGyani's AI-powered listing gain prediction.

GMP Prediction Range
21.6%-29.7%
IPOGyani AI Prediction
-
Actual Listing Gain
+21.5%

Issue & financials

Issue SizeRs 1,550.52 Cr
Fresh IssueRs 0 Cr
OFSRs 1,550.52 Cr
IPO PE32.29
Peer / Sector PE35.00
PE vs Sector Ratio0.92
Latest EBITDA (Cr)40.47
Debt / Equity0.02

Market context at listing

How the broader market moved around the Concord Biotech IPO window. Helpful for isolating how much of the listing gain came from company fundamentals vs. market tailwind.

Nifty 3D Return-0.64%
Nifty 1W Return-0.61%
Nifty 1M Return-2.64%
Nifty during IPO window-1.06%

Concord Biotech IPO - FAQs

What was the listing gain of Concord Biotech IPO?

Concord Biotech IPO listed at +21.5% versus the upper issue price of Rs 741 on 18 August 2023.

How many times was Concord Biotech IPO subscribed?

Concord Biotech IPO was subscribed 24.86x overall. QIB portion was subscribed 67.67x, HNI / NII 16.99x and Retail 3.78x.

What was the IPO GMP for Concord Biotech?

IPO GMP started at Rs 220 on Day 1 and moved to Rs 160 by the close of the issue window. See the day-by-day GMP table above for the full trajectory.

Other IPOs listed in 2023

Browse listed IPOs by year